Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
US8980913B2 · kind B2 · utility
2Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2013 |
| Grant date | Mar 17, 2015 |
| Priority date | — |
| Expiry date | Dec 6, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) defined herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.